Medical breakthrough unlocks rare disease discovery

▴ NEWCASTLE UNIVERSITY
A pioneering study has uncovered 69 previously unknown genetic factors associated with rare diseases, including uncommon forms of epilepsy and schizophrenia.
8th April, 2025: The groundbreaking study, which was published in Nature and involved Newcastle University, used a novel analytical technique to pinpoint the genetic foundation of uncommon diseases, potentially leading to more patient diagnoses and the creation of novel therapeutic interventions. Globally, between 4% and 6% of people suffer from rare diseases. Even after genome sequencing, up to 80% of persons with uncommon diseases go undetected due to a lack of knowledge about the genetic variants that could cause the condition, despite advancements in genetic testing.
An international team of researchers has created rare variant gene burden analysis, an analytical framework for determining the genetic aetiology of Mendelian disorders (mutations in a single gene), to address the problem. The framework was then applied to 34,851 individuals and their family members’ genomic records (a total of 72,690 genomes) from Genomics England's 100,000 Genomes Project.
The study found genetic variations in 69 genes that were previously thought to be linked to rare diseases. In 30 of these instances, the innovative approach's accuracy was confirmed by the new genetic discoveries being corroborated by pre-existing experimental data. The newly identified genetic variations for rare forms of diabetes, schizophrenia, epilepsy, Charcot-Marie-Tooth (CMT) illness, and anterior segment ocular abnormalities were, crucially, backed by the strongest overall genetic and experimental data.
John Sayer, Clinical Professor of Renal Medicine at Newcastle University and Consultant Nephrologist at The Newcastle upon Tyne Hospitals NHS Foundation Trust, stated: "Newcastle has established itself as a global leader in rare disease research, continually advancing genomic medicine to identify new genetic causes and enhance diagnostic and treatment strategies for rare conditions. Our study demonstrates how we are harnessing the power of genetics to improve patient outcomes."
Recruitment of patients for the rare disease component of the Genomics England 100,000 Genomes Project was greatly aided by Newcastle University and Newcastle Hospitals.
Neil Rajan, Professor of Dermatogenetics at Newcastle University and Consultant Dermatologist at Newcastle Hospitals, said: "For patients with rare diseases lacking a known genetic cause, this research highlights how large-scale national genome sequencing projects can provide crucial answers. The 'diagnostic odyssey' remains a significant challenge for the rare disease community, and identifying new genes is an essential step toward improving diagnosis and outcomes for these patients."
To find individuals who would benefit from the trial, Newcastle University's established Rare Diseases Centre and expertise in genetics and clinical genomics were essential. The project team recruited patients and gathered a lot of clinical data by working directly with patients and their families.
The study's principal author, Damian Smedley, a professor of computational genomics at Queen Mary University of London, commented, "The 100,000 Genomes Project data has provided a singular chance to illustrate the clinical utility of extensive statistical techniques in rare illness research. Finding novel genetic connections and ending the diagnostic journey that many patients with rare diseases and their families must endure are made possible by this strategy."
 
ABOUT NEWCASTLE UNIVERSITY: Newcastle University, UK, is a thriving international community of more than 28,000 students from over 130 countries worldwide. As a member of the Russell Group of research-intensive universities in the UK, Newcastle has a world-class reputation for research excellence in the fields of medicine, science and engineering, social sciences, and the humanities. Its academics are sharply focused on responding to the major challenges facing society today. Our research and teaching are world-leading in areas as diverse as health, culture, technology, and the environment. Newcastle University is committed to providing our students with excellent, research-led teaching delivered by dedicated and passionate teachers. Newcastle University is ranked 110th  in the QS World Ranking 2024 and 139th in the Times Higher Education World University Ranking 2023.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026